BVF Inc’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45,757
Closed -$8.36M 43
2025
Q4
$8.36M Sell
45,757
-441,000
-91% -$61.6M 0.28% 34
2025
Q3
$59.1M Sell
486,757
-1,203,464
-71% -$136M 2.4% 15
2025
Q2
$176M Hold
1,690,221
6.3% 5
2025
Q1
$197M Buy
1,690,221
+302,157
+22% +$34.4M 8.03% 2
2024
Q4
$117M Buy
1,388,064
+342,064
+33% +$31.5M 3.98% 4
2024
Q3
$94M Buy
1,046,000
+91,000
+10% +$7.94M 2.75% 10
2024
Q2
$76.9M Buy
+955,000
New +$70.7M 2.15% 14
2024
Q1
Sell
-1,981,100
Closed -$158M 63
2023
Q4
$158M Sell
1,981,100
-150,000
-7% -$10M 3.95% 3
2023
Q3
$149M Hold
2,131,100
4.02% 3
2023
Q2
$153M Hold
2,131,100
4.27% 3
2023
Q1
$131M Buy
2,131,100
+376,100
+21% +$24.7M 4.81% 3
2022
Q4
$135M Buy
+1,755,000
New +$105M 5.71% 2

Other funds holding AXSM